You have 9 free searches left this month | for more free features.

City

Boston (2)

Cincinnati (2)

Louisville (2)

Aurora (1)

Los Angeles (1)

Nashville (1)

New York (1)

Portland (1)

Providence (1)

Condition

Relapsed/Refractory Multiple Myeloma (1)

Tumor, Solid (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

MiNK Therapeutics (2)

Collaborator

Intervention

agent-797 (2)

approved icis (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

agent-797

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed/Refractory Multiple Myeloma Trial in Louisville, Boston (agenT-797)

Active, not recruiting

Relapsed/Refractory Multiple Myeloma

agenT-797

Louisville, Kentucky
+2 more

Oct 21, 2022

Tumor, Solid Trial in United States (agenT-797, Approved ICIs)

Recruiting

Tumor, Solid

agenT-797
Approved ICIs

Los Angeles, California
+8 more

Oct 21, 2022